Ingelheim, Germany/Ridgefield, Connecticut, U.S. Boehringer Ingelheim’s JASCAYD ® (nerandomilast) tablets has been approved by the U.S. Food and Drug Administration (FDA) as an oral treatment option ...
Bishan Home for the Intellectually Disabled is co-developing an app to slow cognitive decline. Read more at straitstimes.com.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results